These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6360818)

  • 1. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision.
    Jespersen J; Astrup T
    Haemostasis; 1983; 13(5):301-15. PubMed ID: 6360818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid microtitre plate screening method for in vitro assessment of fibrinolysis: a preliminary report.
    Paul-Brent PA; Cattley TN; Myers SP; Brooks L; Cheras PA
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):273-8. PubMed ID: 15060427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response curves in the fibrin plate assay. Fibrinolytic acitivity of proteases.
    Haverkate F; Traas DW
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):356-65. PubMed ID: 4450190
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology of the fibrinolytic system].
    Sumi Y
    Nihon Rinsho; 1987 Dec; 45(12):2965-70. PubMed ID: 3128676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A; Tymińska-Brzósko R
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes of the fibrinolytic system of animals induced by injection of tissue plasminogen activator.
    Andreenko GV; Lyutova LV; Shimonaeva EE
    Thromb Res; 1982 Aug; 27(3):279-88. PubMed ID: 6215740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of the fibrinolytic substances in euglobulin solution of man and dog plasma by gel filtration using Sephadex G-100 and 200.
    Nitta H; Sugie I; Sato S; Morimoto S; Miyachi S
    Nagoya Med J; 1967 Mar; 13(1):23-32. PubMed ID: 6075636
    [No Abstract]   [Full Text] [Related]  

  • 14. Simple and sensitive assay employing stable reagents for quantification of plasminogen activator.
    Lewis JG; Pizzo SV; Adams DO
    Am J Clin Pathol; 1981 Oct; 76(4):403-9. PubMed ID: 7197461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel clot lysis assay for recombinant plasminogen activator.
    Jamialahmadi O; Fazeli A; Hashemi-Najafabadi S; Fazeli MR
    Biotechnol Lett; 2015 Mar; 37(3):593-600. PubMed ID: 25351812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for improving the sensitivity and specificity of the fibrin plate.
    Edward N
    J Clin Pathol; 1972 Apr; 25(4):335-7. PubMed ID: 5028641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE; Liutova LV; Andreenko GV
    Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.